Lee Johnson Capital Management’s Amgen AMGN Stock Holding History

Lee Johnson Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,708	Closed	-$601K	–	83
2026 Q1	$601K	Buy	+1,708	New	+$609K	0.22%	57

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Lee Johnson Capital Management's AMGN Position: Q2 2026 in Review

Lee Johnson Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,708 shares — an estimated $601K sold.

Lee Johnson Capital Management first reported a position in AMGN in Q1 2026 and held it in 1 quarter. The position peaked at $601K in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Lee Johnson Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Lee Johnson Capital Management sold 1,708 Amgen shares in Q2 2026, an estimated $601K.
Lee Johnson Capital Management first reported a position in Amgen in Q1 2026 and held it in 1 quarter.
Lee Johnson Capital Management's Amgen position peaked at $601K in Q1 2026.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lee Johnson Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.